// App-Quantinova.ai

: Impact of mepolizumab on work productivity and activity impairment in severe eosinophilic asthma

Researchers

Presenter

  • Necdet B Gunsoy

Principal Investigators

  • Sarah M Cockle

  • Frank C Albers

  • Scott Doyle

  • Rafael Alfonso Cristancho

Medical Centers

  • Value Evidence & Outcomes, GSK, Stockley Park, United Kingdom

  • Value Evidence and Outcomes, GlaxoSmithKline, Brentford, United Kingdom,

  • Respiratory Medical Franchise, GSK, Research Triangle Park, NC, United States,

  • Value Evidence and Outcomes, GSK, Philadelphia, PA, United States of America

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Mepolizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved